Literature DB >> 190880

The biochemistry of the renin-angiotensin system and its role in hypertension.

L T Skeggs, F E Dorer, J R Kahn, K E Lentz, M Levine.   

Abstract

The renin-angiotensin system has an important role in maintaining elevated blood pressure levels in certain forms of experimental and human hypertension. Renin, an enzyme produced by the juxtaglomerular cells of the kidney, acts on a protein substrate found in the alpha 2-globulin fraction of the plasma to produce a decapeptide, angiotensin I. This decapeptide is not directly pressor, but on passage through the pulmonary circulation is converted to an octapeptide, angiotensin II, a very potent pressor substance which acts by causing constriction of arteriolar smooth muscle. In addition to its direct action which increases blood pressure, angiotensin II acts on the adrenal cortex to cause the release of the sodium-retaining hormone aldosterone. Recent evidence suggests that this action may be mediated by the heptapeptide, angiotensin III. Both renin and its protein substrate exist in multiple forms and renin may also exist as a high molecular-weight "pro-hormone," although the physiologic significance of these forms is not clear. The elucidation of the biochemistry of the renin-angiotensin system has provided us with inhibitors which allow the system to be blocked effectively in vivo. Thus, angiotensin antagonists such as Sar 1, IIe 8-angiotensin II and converting enzyme inhibitors such as BPP 9a (SQ 20881) have proved useful in the study of experimental and human hypertension.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 190880     DOI: 10.1016/0002-9343(76)90888-3

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  24 in total

Review 1.  Ovarian hyperstimulation syndrome: a review of pathophysiology.

Authors:  P A Bergh; D Navot
Journal:  J Assist Reprod Genet       Date:  1992-10       Impact factor: 3.412

2.  Primary structure and biological activity of bradykinin potentiating peptides from Bothrops insularis snake venom.

Authors:  A C Cintra; C A Vieira; J R Giglio
Journal:  J Protein Chem       Date:  1990-04

3.  Polymerization of human angiotensinogen: insights into its structural mechanism and functional significance.

Authors:  Peter Stanley; Louise C Serpell; Penelope E Stein
Journal:  Biochem J       Date:  2006-11-15       Impact factor: 3.857

Review 4.  Humoral and neurohormonal aspects of blood pressure regulation: focus on angiotensin.

Authors:  D Ganten; G Stock
Journal:  Klin Wochenschr       Date:  1978

Review 5.  Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current status.

Authors:  Terry K W Ma; Kevin K H Kam; Bryan P Yan; Yat-Yin Lam
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

Review 6.  Renin-angiotensin-aldosterone system: fundamental aspects and clinical implications in renal and cardiovascular disorders.

Authors:  Mark A Perazella; John F Setaro
Journal:  J Nucl Cardiol       Date:  2003 Mar-Apr       Impact factor: 5.952

Review 7.  Drug discovery in renin-angiotensin system intervention: past and future.

Authors:  Bryan Williams
Journal:  Ther Adv Cardiovasc Dis       Date:  2016-04-27

Review 8.  Aliskiren, the first direct renin inhibitor: assessing a role in pediatric hypertension and kidney diseases.

Authors:  Shahid Nadeem; Donald L Batisky
Journal:  Pediatr Nephrol       Date:  2013-12-14       Impact factor: 3.714

Review 9.  Tuftsin, Thr-Lys-Pro-Arg. Anatomy of an immunologically active peptide.

Authors:  M Fridkin; P Gottlieb
Journal:  Mol Cell Biochem       Date:  1981-12-04       Impact factor: 3.396

10.  Inappropriate secretion of antidiuretic hormone in infants with respiratory infections.

Authors:  R P Rivers; M L Forsling; R P Olver
Journal:  Arch Dis Child       Date:  1981-05       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.